Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.780
-0.180 (-6.08%)
At close: May 12, 2025, 4:00 PM
2.760
-0.020 (-0.72%)
After-hours: May 12, 2025, 4:05 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $104.05 million as of May 12, 2025. Its market cap has increased by 14.10% in one year.
Market Cap
104.05M
Enterprise Value
70.74M
1-Year Change
14.10%
Ranking
Category
Stock Price
$2.78
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $104.05M, a decrease of -26.56%. That is a compound annual growth rate of -12.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 110.39M | 37.16% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |